Aldesulfone sodium: Difference between revisions
Appearance
Content deleted Content added
m Stub sorting and placement of stub template(s) |
Updating {{drugbox}} (no changed fields - added verified revid) per Chem/Drugbox validation (report errors or bugs) |
||
Line 1: | Line 1: | ||
{{drugbox |
{{drugbox |
||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid |
| IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid |
||
| image = Aldesulfone.svg |
| image = Aldesulfone.svg |
Revision as of 15:14, 29 July 2010
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Protein binding | 69% |
Metabolism | Hepatic |
Elimination half-life | 3 to 8 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H16N2O6S3 |
Molar mass | 404.485 g/mol g·mol−1 |
3D model (JSmol) | |
| |
(verify) |
Aldesulfone sodium (or sulfoxone) is an antibiotic used in the treatment of leprosy.
Sulfoxone sodium was introduced in Japan in 1948.[1]
References
- ^ PMID 12412600